Pancreatic Transfection in 3D Spheroids and Organoids: Overcoming Barriers to Penetration
2D monolayer cultures inadequately replicate the tumor microenvironment, prompting a shift toward 3D culture systems like spheroids and organoids. However, transfection efficiency in 3D structures is hampered by diffusion barriers, extracellular matrix components, and hypoxic cores.
To overcome these challenges, Altogen’s reagents have been adapted for 3D delivery, employing nano-sized complexes capable of deep tissue penetration. Researchers working with pancreatic organoids derived from Capan-1 or patient samples can now deliver siRNA or CRISPR constructs with enhanced uniformity.
Techniques such as electroporation, microinjection, and PEGylated lipid nanoparticles are also under investigation to improve uptake. Enzymatic softening of the extracellular matrix or transient disruption using Rho kinase inhibitors further enhance accessibility.
Validated readouts include confocal microscopy of reporter signals, single-cell RNA-seq of transfected populations, and high-content imaging. These innovations are driving the next generation of in vitro modeling, offering high-fidelity platforms for gene editing and drug discovery in pancreatic cancer.